DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Primidolol
Primidolol
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
Customs Tariff - Schedule
Ovid MEDLINE(R)
Certain Pharmaceuticals and Intermediate Chemicals: Identification of Applicable 6-Digit HS Subheadings for Products Covered By
(12) Patent Application Publication (10) Pub. No.: US 2007/0155676 A1 Burnett Et Al
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Self-Measured Compared to Office
The Organic Chemistry of Drug Synthesis
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
A Study on Beta Blockers - a Brief Review Tv
Drugs Acting on the Adrenergic Nervous System (Iv)
(11) Application No. AU 2006302237 C1 (19) AUSTRALIAN PATENT OFFICE
Stembook 2018.Pdf
Combinations of Sterol Absorption Inhibitor(S) with Cardiovascular Agent(S) for the Treatment of Vascular Conditions
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
Ep 2459564 B1
United States Patent (10) Patent N0.: US 6,951,860 B2 Mehanna Et A1
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Top View
Marrakesh Agreement Establishing the World Trade Organization
Pharmacophores of the Dual Acting α, β-Blockers As Deduced, from Molecular Dynamics Simulations
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
(12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
Customs Tariff - Schedule Xxi - 1
(12) United States Patent (10) Patent No.: US 9,526,824 B2 Ferrari Et Al
Wo 2007/044693 A2
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Harmonized Tariff Schedule of the United States (2006) Annotated for Statistical Reporting Purposes
Harmonized Tariff Schedule of the United States (2006) (Rev
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2003/0069221A1 Kosoglou Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Ligand P-Gp Inhibition
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
1111111111111111111Imnumu
G.P. Ellis (8).Pdf
Identification and Characterization of Antidiabetic And
E036128.Draft-Revisions.Pdf
Metabolomics Identifies a Biomarker Revealing in Vivo Loss of Functional ß-Cell Mass